GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
11.2888 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
11.2888 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR7, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, XDH |
10.3935 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
10.3584 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
10.3484 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
10.3484 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
10.0227 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
9.852 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, HTR5A, IGF1R, INSR, MMP2, MMP9, PPARA, RORC, SRC, TEK |
9.79848 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, HTR5A, IGF1R, INSR, KDR, MMP2, PPARA, RORC, SMAD3, SRC, TEK |
9.76531 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
9.36661 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, RORC, SMAD3, SRC, TEK |
9.00953 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FLT3, HTR5A, RORC, SRC, TEK |
8.85537 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, DRD2, EGFR, F10, F3, FLT3, GPR35, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
8.583 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, ESR1, FABP3, FLT3, HTR5A, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
8.54342 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
8.44252 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, MET, PPARA |
7.82457 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK |
7.72179 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F10, F3, FABP4, HTR1A, HTR2B, HTR7, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
7.59735 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.59735 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.54435 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
7.2836 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.2836 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
7.28188 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.23082 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.22751 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.09611 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2B, INSR, MET, SMAD3, SRC |
7.03678 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH |
6.95971 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2B, HTR6, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
6.87105 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, HTR1A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, TEK |
6.81194 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.75038 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, HSD11B1, HSD17B1 |
6.67973 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.67268 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
6.63721 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.62616 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP4, FLT3, GPR35, HSPA1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.5267 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.4807 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, RORC, SMAD3, SRC |
6.44916 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2B, INSR, MET, SMAD3 |
6.44916 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2B, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
6.44916 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
6.40982 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
6.38096 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, XDH |
6.37042 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
6.33322 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
6.2489 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.22627 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.21508 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7, SRC, TEK |
6.17982 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.17613 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK |
6.14653 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.07182 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HTR5A, INSR, PPARA, SRC, TEK |
6.05536 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
6.03847 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.94378 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
5.78966 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.78234 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
5.74549 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, RORC, SMAD3, SRC |
5.66375 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, DRD3, DRD5, HTR1A, HTR5A, HTR6, HTR7 |
5.62739 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD11B1, HSD17B1, HTR1A |
5.59132 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.57623 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.56055 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.56055 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.53588 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
5.49866 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, HSPA1A, HTR2B, PIM1, PPARA, XDH |
5.49574 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.49574 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.49574 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
5.49309 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.4266 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.42289 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2B, MMP2, PPARA, SMAD3, SRC, TEK |
5.40013 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
5.38578 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, RORC, SRC |
5.38578 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PTPN1, RORC, SMAD3, SRC |
5.38578 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
5.37732 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
5.37732 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
5.35707 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7, SRC, TEK |
5.31441 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, HTR2B, KDR, SRC |
5.26906 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2B, PPARA, RORC, SRC, TEK |
5.26906 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.26906 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, HSD11B1, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
5.22952 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, HTR7, PPARA, RORC, SRC |
5.22952 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, HTR2B, SMAD3 |
5.22841 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
5.1591 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
5.09558 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, HTR2B, KDR, SRC |
5.09558 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, DRD3, DRD5, HTR1A, HTR5A, HTR7 |
5.08222 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR |
5.03268 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR |
5.03268 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
5.01671 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, INSR, MMP9, PPARA, PTPN1, SMAD3, SRC |
4.99975 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DRD2, DUSP3, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.89872 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.89375 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, KDR, SRC |
4.8917 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HTR5A, RORC, SRC |
4.88988 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FLT3, HSD11B1, HTR5A, INSR, KDR, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
4.88906 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.85074 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, DRD2, EGFR, FLT3, HTR2B, INSR, KDR, PTPN1, SRC, TEK, XDH |
4.80161 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2B, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.79936 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, CDC25B, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.79936 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, HTR2B, KDR, SRC |
4.79936 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.7917 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.75031 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, INSR, SRC |
4.72926 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.6969 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 |
4.69301 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DRD1, DRD5, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RORC, SRC |
4.68941 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.68581 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A |
4.68514 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.68514 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.6664 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
4.66535 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
4.66061 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
4.66061 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, INSR, SMAD3 |
4.65157 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1 |
4.61534 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7 |
4.61244 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7 |
4.61244 |
[BP] GO:0097756 |
None
|
ADORA1, DRD5, HTR1A, HTR2B, HTR7 |
4.60052 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.58227 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.57452 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, PPARA, SMAD3, SRC, TEK |
4.55175 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, PPARA, SMAD3, TEK |
4.53438 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.50145 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.45604 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA |
4.45604 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7 |
4.45391 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7 |
4.43417 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, DUSP3, EGFR, HTR2B, KDR, PTPN1, SRC, TEK |
4.43136 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC, TEK |
4.41392 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.37004 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
4.33068 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.25898 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, HTR2B, INSR, SMAD3, SRC |
4.25897 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PPARA |
4.25576 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.24425 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.23865 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, INSR, PTPN1, SMAD3, SRC, TEK, XDH |
4.20588 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC, TEK |
4.16189 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
4.13388 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.06296 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP4, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
4.05716 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 |
4.03672 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC, TEK |
4.00463 |
[BP] GO:0055080 |
cation homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
3.9851 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.98379 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
3.96923 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.95762 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.95483 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
3.9542 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.95059 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
DRD1, DRD2, DRD3, DRD5, EGFR, HTR2B, HTR5A, KDR |
3.9336 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
3.92311 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
3.79824 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK |
3.79824 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, HTR2B, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.78689 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
3.78689 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.78689 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.78689 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.78478 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HSPA1A, HTR2B, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
3.78478 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
3.78478 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC |
3.78478 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.75633 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC |
3.75002 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.70511 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.70511 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DRD2, EGFR, FLT3, HTR2B, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.67143 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, DRD5, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC |
3.66146 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.65802 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, DRD5 |
3.64952 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2B |
3.64952 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.64131 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
3.64131 |
[BP] GO:0042310 |
None
|
DRD5, HTR1A, HTR2B, HTR7 |
3.61607 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.59342 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.57576 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
3.55106 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
3.54974 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR |
3.52379 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.50804 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2B, PPARA, SRC, TEK |
3.50738 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.50336 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.49058 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, HTR1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK |
3.48909 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, CDC25B, DRD2, EGFR, FLT3, HTR2B, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.4878 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.48386 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
3.47979 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.47333 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.47333 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3, DRD5 |
3.4668 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
3.46642 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, HTR2B, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, SRC |
3.46481 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, EGFR, HTR2B, KDR, SRC, TEK |
3.45438 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC, TEK |
3.44564 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, DRD5 |
3.44078 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.44078 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
3.41823 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR2B, SRC |
3.41074 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
3.39489 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
3.38029 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
3.36111 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.3564 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, SRC, TEK |
3.35107 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
3.32301 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.3225 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC |
3.31004 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA, RORC |
3.31004 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, INSR |
3.31004 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A |
3.30287 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
3.28876 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.26137 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.26137 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, GPR35, HCAR2, HSPA1A, HTR2B, INSR, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, XDH |
3.24523 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.21741 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, MET, PPARA, PTPN1, RORC, SMAD3, SRC |
3.19172 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
3.18209 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
3.18067 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
3.16078 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
3.14463 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MET, PIM1, SRC, TEK |
3.14033 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.11979 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.11979 |
[BP] GO:0060158 |
None
|
DRD1, DRD2, DRD5 |
3.11979 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
3.11839 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA, SMAD3 |
3.11458 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
3.11374 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
3.11194 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, DRD5, ESR1, HTR2B |
3.10639 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, HTR1A, HTR2B, INSR, PPARA |
3.09702 |
[BP] GO:0046960 |
None
|
DRD1, DRD5 |
3.08622 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC |
3.07671 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, HTR2B, SMAD3 |
3.06831 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, HTR2B, INSR, PTPN1, SRC, TEK |
3.04913 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.04038 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
3.04038 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.04038 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
3.04038 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR |
3.03745 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, HTR2B, IGF1R, INSR, MET, PPARA, RORC, SMAD3, SRC |
3.03638 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, DRD2, DRD3, EGFR, HCAR2, HTR2B, PTPN1, SMAD3, SRC |
3.03404 |
[BP] GO:0019933 |
None
|
DRD1, DRD2, DRD3, DRD5, HTR5A |
3.03182 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, HTR2B, INSR, PTPN1, SRC, TEK |
2.99291 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.97199 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.91672 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.91672 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC |
2.91672 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.90825 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.88803 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.88302 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.87837 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.87837 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.87627 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2B, HTR7 |
2.87627 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.87523 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.86593 |
[BP] GO:0019935 |
None
|
DRD1, DRD2, DRD3, DRD5, HTR5A |
2.85938 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, HTR2B, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.84925 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.84925 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.84925 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.84925 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.84925 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.84925 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.84061 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ESR1, FABP4, FLT3, FUT7, HTR2B, KDR, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK |
2.83936 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR |
2.83252 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC |
2.82066 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.80459 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.79698 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, PIM1, PPARA, RORC, SRC |
2.79317 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, EGFR, HCAR2, HTR2B, MET, PPARA, SMAD3 |
2.77772 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, HTR2B, INSR, PTPN1, SRC |
2.76846 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
2.75747 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.75448 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, HTR2B, MMP9, NUAK1, PTPN1, SMAD3, SRC, XDH |
2.74388 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.74008 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, INSR, MMP2, MMP9, SRC |
2.73863 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, GPR35, HTR1A, MMP9 |
2.72839 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
2.72491 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.71784 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.71784 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.71784 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.71784 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.69871 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.69871 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.69871 |
[BP] GO:0007617 |
None
|
APP, DRD1, DRD5 |
2.69871 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.69871 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.69599 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.69599 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR |
2.69172 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, CDC25B, DRD2, EGFR, FLT3, HTR2B, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.68777 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, HTR1A, HTR2B, HTR7, INSR, SRC, TEK |
2.65071 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.64588 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, RORC |
2.64588 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.64588 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.64588 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.64588 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
2.63408 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.63201 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HTR2B, IGF1R, INSR, PTPN1, SRC |
2.63201 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.62897 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
2.62897 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CSNK2A1, EGFR, HCAR2, HSPA1A, HTR2B, INSR, KDR, MET, PPARA, PTPN1, SMAD3 |
2.62231 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.62231 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.61558 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.61558 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR |
2.59989 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.59512 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.59512 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.59174 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, HTR2B, INSR, PTPN1, SRC |
2.57305 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1 |
2.54834 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HTR2B, SMAD3 |
2.54607 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.53817 |
[BP] GO:0040008 |
regulation of growth
|
APP, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 |
2.51719 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA |
2.51306 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.483 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.483 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.48237 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.47745 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.46684 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.44974 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.44974 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.43818 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.43818 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43818 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, PPARA, RORC, SRC |
2.41455 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.4111 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.3891 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.38799 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2B, SRC |
2.38309 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.38154 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, DRD1, DRD5, EGFR, ESR1, SRC |
2.37775 |
[BP] GO:0001936 |
None
|
F3, HTR2B, KDR, TEK, XDH |
2.37718 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.37467 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, FABP4, HSPA1A, HTR2B, IGF1R, MET, MMP9, PPARA, PTPN1, RORC, SMAD3, SRC, XDH |
2.37279 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.36989 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.34959 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.34959 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.34959 |
[BP] GO:0007189 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.30452 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, PPARA |
2.28128 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, GPR35, MMP9 |
2.26774 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.26437 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.26437 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.26437 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.26437 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.26437 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.26437 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.26437 |
[BP] GO:0050678 |
None
|
EGFR, F3, HTR2B, KDR, SMAD3, TEK, XDH |
2.26437 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.25014 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.24965 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, PTPN1, SRC |
2.23712 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3 |
2.23125 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.23125 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.23125 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, EGFR, HCAR2, HTR2B, SRC |
2.22897 |
[BP] GO:0019098 |
None
|
APP, DRD1, DRD5 |
2.22897 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR |
2.22897 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD5, EGFR |
2.21769 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.21607 |
[BP] GO:0042060 |
None
|
DRD5, EGFR, PPARA, SMAD3 |
2.21607 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, FUT7, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.21418 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.20824 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.19914 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.19581 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.1933 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.1933 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2B, SRC |
2.16547 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CSNK2A1, DRD2, DRD3, DRD5, DUSP3, FABP4, IGF1R, MMP9, PTPN1, SRC |
2.15969 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
2.15969 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.15969 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, DRD5 |
2.15969 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.15969 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.15969 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2 |
2.15969 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.15969 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, HTR2B, INSR, PTPN1, SRC |
2.13174 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, DRD5 |
2.13174 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.13174 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, SMAD3, SRC |
2.13174 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD17B1, XDH |
2.13174 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.13174 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.13174 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.13174 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.13174 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.13174 |
[BP] GO:0046958 |
None
|
DRD1, DRD5 |
2.13174 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.13174 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.12912 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.12268 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.12268 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.11535 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.10875 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.10153 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.10153 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.10153 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, ESR1, HTR2B |
2.10153 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, HCAR2, HTR2B, SMAD3, SRC |
2.08931 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.08598 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, MMP9 |
2.07475 |
[BP] GO:0001938 |
None
|
F3, HTR2B, KDR, TEK |
2.07475 |
[BP] GO:0071868 |
None
|
APP, DRD1, DRD5 |
2.07042 |
[BP] GO:0071870 |
None
|
APP, DRD1, DRD5 |
2.07042 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.06672 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.04153 |
[BP] GO:0007267 |
None
|
ADORA1, DRD1, DRD2, DRD3, DRD5, ESR2, HTR6, HTR7, TEK |
2.03515 |
[BP] GO:0090066 |
None
|
ADORA1, DRD1, DRD5, EGFR, HTR1A, HTR2B, HTR7 |
2.03114 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, MET |
2.02612 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6 |
2.01577 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2D6 |
2.01577 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2D6 |
2.01577 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A |
2.01433 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.01433 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
EGFR, ESR1, HTR2B |
2.01046 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.01046 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, PPARA, RORC, SRC |
2.01003 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A |
2.00492 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, DRD1, DRD2, DRD3, DRD5, F10, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
7.22517 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK |
6.82217 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F10, F3, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SRC, TEK |
5.80739 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
5.49481 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PTPN1, SRC, TEK |
4.23918 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK |
4.20718 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC |
3.13932 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA4, CA9, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
2.73871 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.67701 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.64588 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, DRD1, DRD2, DRD5, EGFR, INSR, MET, SRC, TEK |
2.37886 |
[CC] GO:0097730 |
None
|
DRD1, DRD2, DRD5 |
2.13174 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.13174 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
12.0106 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
10.3484 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.322 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
9.99264 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
8.95454 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, SMAD3, TEK |
8.88028 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, PPARA, RORC, TEK |
8.70937 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, DRD5, HTR1A, HTR2B, HTR5A, HTR7 |
8.64123 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK |
8.07036 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.67586 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
7.59735 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, TEK |
7.59735 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, F10, HTR1A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
7.2836 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, DRD5, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
7.2836 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.00384 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
6.69739 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.63817 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.82105 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.66375 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.56055 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.49574 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.49574 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.35707 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.19919 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
5.17584 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
5.17584 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
5.07224 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD5 |
5.02979 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.8917 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
4.64772 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.59574 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.32028 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.20718 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2B, HTR5A, HTR7 |
4.03672 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, XDH |
3.95483 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.79824 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.60945 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.55396 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.49237 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.45606 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
3.43987 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, DRD1, DRD2, DRD3, DRD5, GPR35, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
3.39489 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC |
3.27851 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.14033 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.11374 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.08622 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
3.00516 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.94654 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, F10, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
2.87627 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FLT3, HSD17B1, HSPA1A, HTR1A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
2.87048 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.84925 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.84925 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.81866 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD17B1, XDH |
2.78951 |
[MF] GO:0005102 |
receptor binding
|
ADORA1, APP, DRD2, DRD3, EGFR, ESR1, ESR2, FLT3, HSPA1A, HTR1A, IGF1R, INSR, KDR, PTPN1, SMAD3, SRC |
2.69605 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.59989 |
[MF] GO:0001588 |
None
|
DRD1, DRD5 |
2.44974 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.44974 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.44974 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.41455 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, F10, F3, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.4111 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, XDH |
2.33867 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.26437 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.26437 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.22897 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.15969 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.13174 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.12912 |
[MF] GO:0043168 |
anion binding
|
APP, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.10251 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, SRC, XDH |
2.07882 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, HSD17B1, RORC |
2.07475 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6 |
2.07042 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, SMAD3, SRC |
2.04153 |
[MF] GO:0019902 |
phosphatase binding
|
EGFR, MET, PPARA, PTPN1, SMAD3 |
2.03515 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.01577 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
EGFR, ESR1 |
2.01577 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.01577 |